Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNTARA LIMITED Call Transcript 2012

Jul 15, 2012

65830_rns_2012-07-15_dc46b336-6699-46cb-879e-b26a49c2fb3b.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Media Release

16 July 2012

==> picture [153 x 23] intentionally omitted <==

==> picture [153 x 24] intentionally omitted <==

PHARMAXIS QUARTERLY INVESTOR CONFERENCE CALL

Pharmaxis Ltd (PXS) will release its June 2012 Quarterly Report to Shareholders on the afternoon of Tuesday 17[th] July 2012. Pharmaxis CEO, Dr Alan Robertson, will host an investor teleconference the following morning to review the quarter and answer investor questions.

The teleconference will be on Wednesday 18[th] July 2012 at 8.30am (Sydney time).

Telephone access (toll free):  Australia: 1800 838 758 or 1800 131 617  USA/Canada: 1855 237 2970  UK: 0800 051 4282  NZ: 0800 447 258

Telephone access (metered): +61 2 9009 0730

Online access details are available on the Pharmaxis website home page at: www.pharmaxis.com.au

A recording of the conference will be available on the Pharmaxis website home page approximately 3 hours after the call.

SOURCE: Pharmaxis Ltd, Sydney, Australia CONTACT: Pharmaxis Investor Relations T: +61 2 9454 7200, F: +61 2 9451 3622, E: [email protected] Website: www.pharmaxis.com.au

Page 1 of 1